Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...

Return on Equity (ROE): Illumina's ROE excels beyond industry benchmarks, reaching 8.31%. This signifies robust financial management and efficient use of shareholder equity capital. Return on ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

Illumina's shares slid 2.8% to $81.81 in premarket U.S. trading ... Boerse's Clearstream to offer bitcoin and ether custody services 10:05 PM UTC · Updated ago Reuters, the news and media ...

Here are the biggest headlines of the day in the latest Market Minute. Illumina (ILMN) shares have recouped their losses. The stock had fallen after China banned it from exporting its gene ...

Illumina has a fifty-two week low of $80.18 and a fifty-two week high of $156.66. The stock has a market capitalization of $13.45 billion, a PE ratio of -11.05, a P/E/G ratio of 1.60 and a beta of ...

Illumina is reducing its forecast for this year ... month in nearly 23 years.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyRemembering the Landscape ...

SHANGHAI - China announced a ban on March 4 on imports of genetic sequencers from US medical equipment maker Illumina ... a subsidiary of BGI, jumped 8.4 per cent on March 4 and MGI Tech, a ...

Since inception, the Global Leaders UCITS C-share USD has delivered an annualized 11.4% net after fees, surpassing firm’s target, compared to the MSCI ACWI’s 8.9%. In addition, please check ...

China’s Ministry of Commerce said it would ban Illumina, a San Diego company, from importing its gene-mapping products in China. Illumina is the world’s leading producer of gene-sequencing ...

MGI and BGI have denied such allegations. Illumina's shares slid 2.8% to $81.81 in premarket U.S. trading. Its business in the country has already been under pressure from stiff competition ...